Evidence map›Paper›PMID 38627947›Full record

ReviewBMB reports2024

Gut microbiota-generated metabolites: missing puzzles to hosts' health, diseases, and aging.

Yan Zhang, Shibo Wei, Hang Zhang, Yunju Jo, Jong-Sun Kang, Ki-Tae Ha, Jongkil Joo, Hyun Joo Lee, Dongryeol Ryu

Open access · goldAbstract readReview
In one paragraph

Review in BMB reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Observational
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Yan ZhangDepartment of Molecular Cell Biology, Single Cell Network Research Center, Sungkyunkwan University, Suwon 16419, Korea.
Shibo WeiDepartment of Biomedical Science and Engineering, Gwangju Institute of Science and Technology (GIST), Gwangju 61005, Korea.
Hang ZhangDepartment of Hepatobiliary and Pancreatic Surgery, The Second Hospital of Jilin University, Changchun 130041, China.
Yunju JoDepartment of Biomedical Science and Engineering, Gwangju Institute of Science and Technology (GIST), Gwangju 61005, Korea.
Jong-Sun KangDepartment of Molecular Cell Biology, Single Cell Network Research Center, Sungkyunkwan University, Suwon 16419, Korea.
Ki-Tae HaDepartment of Korean Medical Science, School of Korean Medicine, Pusan National University, Yangsan 50612, Korea.
Jongkil JooDepartment of Obstetrics and Gynecology, Pusan National University Hospital, Busan 49241, Korea.
Hyun Joo LeeDepartment of Obstetrics and Gynecology, Pusan National University Hospital, Busan 49241, Korea.
Dongryeol RyuDepartment of Biomedical Science and Engineering, Gwangju Institute of Science and Technology (GIST), Gwangju 61005, Korea.
Gwangju Institute of Science and Technology · KRPusan National University Hospital · KRSungkyunkwan University · KRPusan National University · KRSecond Affiliated Hospital of Jilin University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The gut microbiota, an intricate community of bacteria residing in the gastrointestinal system, assumes a pivotal role in various physiological processes. Beyond its function in food breakdown and nutrient absorption, gut microbiota exerts a profound influence on immune and metabolic modulation by producing diverse gut microbiota-generated metabolites (GMGMs). These small molecules hold potential to impact host health via multiple pathways, which exhibit remarkable diversity, and have gained increasing attention in recent studies. Here, we elucidate the intricate implications and significant impacts of four specific metabolites, Urolithin A (UA), equol, Trimethylamine N-oxide (TMAO), and imidazole propionate, in shaping human health. Meanwhile, we also look into the advanced research on GMGMs, which demonstrate promising curative effects and hold great potential for further clinical therapies. Notably, the emergence of positive outcomes from clinical trials involving GMGMs, typified by UA, emphasizes their promising prospects in the pursuit of improved health and longevity. Collectively, the multifaceted impacts of GMGMs present intriguing avenues for future research and therapeutic interventions. [BMB Reports 2024; 57(5): 207-215].

Indexed as

AgingGastrointestinal MicrobiomeMethylaminesAnimalsCoumarinsEquolHumansImidazolesPropionates3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-oneCoumarinsEquolImidazolesMethylaminesPropionatestrimethyloxamine

Identifiers

PMID38627947
PMCPMC11139682
OpenAlexW4394874186

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.